Crownlink
Databases
Biospecimen Request
Our Services
Oncology & IO Solutions
Preclinical Services
Patient-Derived Translational Oncology
Biomarker & Bioanalysis Services
Clinical Biomarker & Biospecimen Services
Bioinformatics & Data Solutions
Therapeutic Modalities
ADCs
Cell & Gene Therapy
Radiopharmaceuticals
Cancer Indications
AML / Liquid Tumors
Breast Cancer
Drug Targets
KRAS
EGFR
IO Targets
PARP
Drug Resistance
Drug Combinations
Drug Discovery
Target Discovery & Validation
Drug Screening
Efficacy
Pharmacology
In Silico Solutions
Consulting
In Vitro Services
Cell Lines & Panels
OmniScreen
Patient-derived Organoids
Organoid Xplore
Drug Screening & Combination Analysis
Complex IO Assays
High Content Imaging
DMPK / Tox
In Vivo DMPKT
Bioanalysis
Engineered Models & Services
Target KO & CRISPR
In Vivo Services
PDX Models
CDX Models
Syngeneic Models
Humanized GEMMs
Tumor Homografts
Humanized Models
(HSC & PBMC)
Orthotopic / Metastatic &
Imaging-enabled Models
Imaging Technology
Digital Pathology
High Content Imaging
Patient Derived Systems
PDX Mouse Clinical Trials
Organoid and Matched PDX
Ex Vivo Patient Tissue
3D Bone Marrow Models
Biomarker Discovery Services
OmniScreen
Organoid Xplore
PDX Mouse Clinical Trials
Spatial Biology &
Tissue-based Biomarker Analysis
Histology & Immunostaining
(H&E, IHC, IF, mIF)
NanoString GeoMx
10x Genomics Visium
Tumor Tissue Microarrays
Digital Pathology
Protein Analysis
Immunoassays
(ELISA, MSD, Luminex)
Flow Cytometry
Mass Spec-proteomics
Discovery Proteomics
PTM Proteomics & Phosphoproteomics
Rare Cell Analysis
DNA / RNA Analysis
Standard Genomics
Next Generation Sequencing
Single Cell Sequencing
NanoString nCounter
Optical Genome Mapping
Mouse I/O RNA-seq Panel
Microbiome Sequencing
NanoString GeoMx
10x Genomics Visium
Cell Line Authentication
Model-derived Biobank
Tumor Tissue Microarrays
Immune Monitoring
Bioanalysis
Biofluid Testing
Regulatory Accreditations
Specialty Biomarker Services
Longitudinal Plasma
Clinical Biomarkers
Human Biospecimens
Preclinical Cancer Model Databases
Drug Combinations
Bioinformatics Consulting
Preclinical Biomarker Discovery
Omics Data Analysis
Oncology & IO Solutions
Therapeutic Modalities
ADCs
Cell & Gene Therapy
Radiopharmaceuticals
Cancer Indications
AML / Liquid Tumors
Breast Cancer
Drug Targets
KRAS
EGFR
IO Targets
PARP
Drug Resistance
Drug Combinations
Drug Discovery
Target Discovery & Validation
Drug Screening
Efficacy
Pharmacology
In Silico Solutions
Consulting
Preclinical Services
In Vitro Services
Cell Lines & Panels
OmniScreen
Patient-derived Organoids
Organoid Xplore
Drug Screening & Combination Analysis
Complex IO Assays
High Content Imaging
DMPK / Tox
In Vivo DMPKT
Bioanalysis
Engineered Models & Services
Target KO & CRISPR
In Vivo Services
PDX Models
CDX Models
Syngeneic Models
Humanized GEMMs
Tumor Homografts
Humanized Models
(HSC & PBMC)
Orthotopic / Metastatic &
Imaging-enabled Models
Imaging Technology
Digital Pathology
High Content Imaging
Patient-Derived Translational Oncology
Patient Derived Systems
PDX Mouse Clinical Trials
Organoid and Matched PDX
Ex Vivo Patient Tissue
3D Bone Marrow Models
Biomarker Discovery Services
OmniScreen
Organoid Xplore
PDX Mouse Clinical Trials
Biomarker & Bioanalysis Services
Spatial Biology &
Tissue-based Biomarker Analysis
Histology & Immunostaining
(H&E, IHC, IF, mIF)
NanoString GeoMx
10x Genomics Visium
Tumor Tissue Microarrays
Digital Pathology
Protein Analysis
Immunoassays
(ELISA, MSD, Luminex)
Flow Cytometry
Mass Spec-proteomics
Discovery Proteomics
PTM Proteomics & Phosphoproteomics
Rare Cell Analysis
DNA / RNA Analysis
Standard Genomics
Next Generation Sequencing
Single Cell Sequencing
NanoString nCounter
Optical Genome Mapping
Mouse I/O RNA-seq Panel
Microbiome Sequencing
NanoString GeoMx
10x Genomics Visium
Cell Line Authentication
Model-derived Biobank
Tumor Tissue Microarrays
Immune Monitoring
Bioanalysis
Biofluid Testing
Clinical Biomarker & Biospecimen Services
Regulatory Accreditations
Specialty Biomarker Services
Longitudinal Plasma
Clinical Biomarkers
Human Biospecimens
Bioinformatics & Data Solutions
Preclinical Cancer Model Databases
Drug Combinations
Bioinformatics Consulting
Preclinical Biomarker Discovery
Omics Data Analysis
Publications & Resources
Blog
Podcast
Publications
Resources
Blog
Podcast
Publications
Resources
About Us
Company
Leadership & SAB
News & Events
Careers
Awards & Testimonials
Company
Leadership & SAB
News & Events
Careers
Awards & Testimonials
Crownlink
Databases
Biospecimen Request
Contact Us
Contact Us
This is a search field with an auto-suggest feature attached.
There are no suggestions because the search field is empty.
Crown Bioscience Blog
Jun 23, 2025
Marianne Baillargeon
|
Preclinical Modeling
How to use in vitro models to study and overcome drug resistance in oncology
Learn More
Jun 11, 2025
Solid Tumor Indications
Patient Tumor Samples and Mass Spectrometry: Unveiling Molecular Signatures in Cancer Research
Learn More
Jun 3, 2025
Spatial Biology
|
Biospecimens
|
Biomarkers & Diagnostics
Spatial Data Analysis of Patient Tumor Samples: A New Frontier in Oncology Research
Learn More
May 27, 2025
Preclinical Modeling
From Organoid Co-Cultures to Functional Tumoroids: Pushing Boundaries in In Vitro Models
Learn More
May 23, 2025
Preclinical Modeling
Syngeneic Models in Cancer Research: Bridging the Gap Between In Vivo and Clinical Studies
Learn More
May 21, 2025
Preclinical Modeling
Redefining Precision Medicine with Organoids: Insights from Crown Bioscience
Learn More
May 19, 2025
Podcast
|
Biomarkers & Diagnostics
Transforming Oncology Drug Development: The Power and Potential of Biomarkers
Learn More
May 19, 2025
Biomarkers & Diagnostics
Tumor Tissue Microarrays (TMAs): Importance, Applications, and Role in Drug Discovery
Learn More
May 15, 2025
Targeted Therapeutics
The next generation of antibody-drug conjugates: pan-cancer ADCs
Learn More
Prev
1
...
2
3
4
5
6
...
30
Next